SMITH GIRI

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BIRMINGHAM, AL NPI 1275975534

General Payments — all program years on this page

$35,265.94

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $24,198.94 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $4,314.001
2022 $5,103.001
2023 $1,650.001
2024 $24,198.9416

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077589525 Janssen Research & Development, LLC $1,961.32 08/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589527 Janssen Research & Development, LLC $980.50 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589529 Janssen Research & Development, LLC $980.70 10/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589531 Janssen Research & Development, LLC $980.60 02/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589533 Janssen Research & Development, LLC $1,395.46 06/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589535 Janssen Research & Development, LLC $980.50 03/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589537 Janssen Research & Development, LLC $980.60 03/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589539 Janssen Research & Development, LLC $980.60 07/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1077589541 Janssen Research & Development, LLC $980.68 04/18/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078291651 Janssen Scientific Affairs, LLC $1,562.50 05/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078291654 Janssen Scientific Affairs, LLC $550.00 08/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1086959559 Novartis Pharmaceuticals Corporation $20.30 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140000429 GENZYME CORPORATION $7,064.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1140000449 GENZYME CORPORATION $187.57 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140000451 GENZYME CORPORATION $4,571.00 11/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1150259924 Adaptive Biotechnologies Corporation $22.61 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.